adzenys er
Generic: amphetamine
adzenys er: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Neos Therapeutics, Inc. (NEOS) | Approved |
FDA Decisions
Approval(NEOS)
Frequently asked questions
Who is developing adzenys er?
adzenys er is being developed by Neos Therapeutics, Inc..
What is adzenys er's latest FDA decision?
The most recent tracked FDA decision for adzenys er is Approval, dated September 15, 2017.
Get deeper analysis on adzenys er
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis